Value of liver biopsy in the diagnosis and clinical trial of non-alcoholic fatty liver disease
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 11
Abstract
Non-alcoholic fatty liver disease (NAFLD) constitutes a series of histological lesions characterized by varying degrees of hepatocyte damage, fat accumulation, inflammation, and fibrosis. Currently, liver biopsy is considered the “gold standard” for evaluating the degree of hepatic steatosis, inflammation, and fibrosis, and it also serves as the cornerstone for accurate grading of NAFLD. This article reviews the value and application of liver biopsy in the clinical diagnosis, staging, and clinical trials of NAFLD.
Authors and Affiliations
Qichao GE, Lungen LU
Unified consensus and evolution of the definition of acute-on-chronic liver failure: Seeking common ground while reserving differences
The concept of acute-on-chronic liver failure (ACLF) has been introduced for nearly 30 years, and with extensive research on its pathogenesis, diagnostic criteria, and treatment strategies, related consensus statem...
Risk factors for the prognosis of elderly patients with hepatitis B virus-related acute-on-chronic liver failure and construction of a nomogram model for risk prediction
[Objective] To investigate the clinical features of elderly patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) and the risk factors affecting the short-term prognosis of patients. [Method...
The genetic association between nonalcoholic fatty liver disease and type 2 diabetes mellitus in different body mass index categories: A bidirectional Mendelian randomization study
[Objective] To investigate the genetic association between nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) using bidirectional two-sample Mendelian randomization (MR), as well as the c...
Systemic therapy for advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignancies with high morbidity and mortality rates worldwide. With the advances in molecular biology and tumor immunology, molecular-targeted agents represent...
Expression of CXCL10 and CXCL12 in gallbladder carcinoma and their mechanism of action in tumor invasion
[Objective] To investigate the expression levels of CXCL10 and CXCL12 in gallbladder carcinoma and their mechanism of action in tumor invasion. [Methods] Tumor tissue samples and adjacent tissue samples were collected fr...